Second-line Immunotherapy for ES-SCLC
Second-line Immunotherapy for ES-SCLC
Recruiting · NCT06853678 · Registry updated 2025-03-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Second-line Immunotherapy for ES-SCLC | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Recruiting | Not applicable | 2025-03-03 | NCT06853678 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Medical University Cancer Institute and Hospital | Tianjin | China | 20 |